Published in Medical Letter on the CDC and FDA, July 30th, 2006
Study 1: Scientists compare potential protection induced by three vaccination strategies against Leishmania major infection in a recent issue of the journal Vaccine.
According to their report, "Signal peptidase (SPase) is an essential enzyme in both prokaryotes and eukaryotes, which removes signal sequence from secretary proteins. Previously, type I SPase from Leishmania major (Lmjsp) has been isolated and characterized."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.